NASDAQ · EVO
Evotec SE
Healthcare · Drug Manufacturers - Specialty & Generic
$1.57
Up+$0.08 (+4.78%)
Updated Nov 5, 2026, 7:19 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.08B
- P/E ratio
- -6.02
- Dividend yield
- 0.00%
- 52-week range
- $1.33 – $3.41
- Volume
- 55.74K
- Avg. volume
- 69.26K
Price performance · EVO
EVO price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
EVO closed at $1.57 after 21 trading sessions, down 2.48% for the selected period.
- Last close
- $1.57
- Period change
- -2.48%
- Period low
- $1.35
- Period high
- $1.61
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $1.58 | $1.59 | $1.5301 | $1.57 | 55.74K |
| Nov 3, 2026 | $1.55 | $1.57 | $1.534 | $1.55 | 30.11K |
| Nov 2, 2026 | $1.52 | $1.54 | $1.50 | $1.52 | 67.64K |
| Oct 30, 2026 | $1.565 | $1.565 | $1.50 | $1.53 | 73.25K |
| Oct 29, 2026 | $1.59 | $1.59 | $1.55 | $1.58 | 64.14K |
| Oct 28, 2026 | $1.57 | $1.61 | $1.57 | $1.605 | 145.67K |
| Oct 27, 2026 | $1.52 | $1.57 | $1.52 | $1.57 | 42.42K |
| Oct 26, 2026 | $1.51 | $1.54 | $1.51 | $1.52 | 121.49K |
| Oct 23, 2026 | $1.50 | $1.53 | $1.50 | $1.50 | 20.61K |
| Oct 22, 2026 | $1.56 | $1.56 | $1.53 | $1.54 | 51.81K |
| Oct 21, 2026 | $1.50 | $1.56 | $1.50 | $1.56 | 53.02K |
| Oct 20, 2026 | $1.43 | $1.49 | $1.43 | $1.48 | 85.71K |
| Oct 19, 2026 | $1.41 | $1.44 | $1.41 | $1.42 | 77.57K |
| Oct 16, 2026 | $1.43 | $1.43 | $1.38 | $1.38 | 82.4K |
| Oct 15, 2026 | $1.44 | $1.44 | $1.39 | $1.42 | 123.98K |
| Oct 14, 2026 | $1.48 | $1.48 | $1.41 | $1.425 | 158.37K |
| Oct 13, 2026 | $1.345 | $1.35 | $1.33 | $1.345 | 113.96K |
| Oct 12, 2026 | $1.44 | $1.44 | $1.36 | $1.37 | 182.62K |
| Oct 9, 2026 | $1.56 | $1.57 | $1.53 | $1.53 | 40.01K |
| Oct 8, 2026 | $1.59 | $1.595 | $1.5304 | $1.57 | 94.42K |
| Oct 7, 2026 | $1.60 | $1.63 | $1.58 | $1.61 | 93.14K |
Latest EVO news
The latest Smart Investors Daily articles mentioning EVO.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

